The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors
Abstract This study aims to investigate the prognostic value of the systemic immune-inflammation index (SII)and its impact on survival in patients with metastatic renal cell carcinoma (mRCC). A total of 706patients with mRCC treated with tyrosine kinase inhibitors (TKIs)between January 2007 and June...
Main Authors: | Kadriye Bir Yücel, Emre Yekedüz, Serdar Karakaya, Deniz Tural, İsmail Ertürk, Cihan Erol, Özlem Ercelep, Nihan Şentürk Öztaş, Çağatay Arslan, Gökhan Uçar, Ahmet Küçükarda, Özlem Nuray Sever, Saadettin Kılıçkap, Orçun Can, Satı Coşkun Yazgan, Berna Öksüzoğlu, Nuri Karadurmuş, Mehmet Ali Şendur, Yüksel Ürün |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-20056-3 |
Similar Items
-
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study
by: Deniz Can Guven, et al.
Published: (2024-01-01) -
Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?
by: Emre Yekedüz, et al.
Published: (2021-03-01) -
Which is the best for cancer treatment? Surgery or chemotherapy
by: Nuri Karadurmuş, et al.
Published: (2017-04-01) -
Retrospective evaluation of malignant melanoma patients: A single-center experience
by: Mustafa Solak, et al.
Published: (2021-05-01) -
Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review
by: Deniz C. Guven, et al.
Published: (2021-11-01)